← All indications
Obesity, Morbid
The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.
Drugs by status
Phase 4 trials (38)
- propofol
- vitamin d3
- phentermine
- bismuth subsalicylate
- cefazolin
- chenodeoxycholic acid
- colesevelam
- ibuprofen
- micafungin
- sevoflurane
- liraglutide
- naltrexone
- icosapent ethyl
- indocyanine green
- mangosteen
- ursodeoxycholic acid
- acetaminophen
- posaconazole
- anidulafungin
- remimazolam
- rocuronium
- semaglutide
- bupivacaine
- anastrozole
- amphotericin b
- dexmedetomidine
- bupropion
- amino acids
- midazolam
- tranexamic acid
- +8 more
Phase 3 trials (15)
Phase 2 trials (11)
Phase 1 trials (13)
Organizations
Organization Involved with Phase 4 Indications (31)
- Astellas
- AstraZeneca
- Merck
- University of Roma La Sapienza
- Baylor University
- Cornell University
- Duke University
- Hospital Juarez de Mexico
- Inonu University
- MemorialCare Health System
- Ondokuz Mayıs University
- Osaka University
- Radboud University
- Rijnstate Hospital
- University of Oslo
- University of Taubate
- Columbia University
- Istanbul University
- University of California, Irvine
- University of Copenhagen
- Icahn School of Medicine at Mount Sinai
- University of Freiburg
- Long Beach Memorial Medical Center
- Associated Professor Doctor Gulay ERDOGAN KAYHAN
- University of Missouri
- St. Antonius Hospital, Nieuwegein
- Rode Kruis Ziekenhuis
- Government of Turkey
- People's Liberation Army of China
- University of Lorraine
- +1 more
Organization Involved with Phase 3 Indications (13)
- Rhythm Pharmaceuticals, Inc.
- Advanced Specialty Care
- Ain Shams University
- University of Padova
- University of Patras
- University of Alberta
- University of Naples Frederico II
- National Medical Centre Siglo XXI Mexican Institute for Social Security
- University of Paris
- Rouen Normandy University
- University of Caen-Normandie
- University of Picardie Jules Verne
- Government of Kuwait
Organization Involved with Phase 2 Indications (22)
- Fundacion IMIM
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Hamdard University
- Hospital Dona Helena
- Johns Hopkins University
- Mansoura University
- Norwegian University of Science and Technology
- Shifa Ul Mulk Memorial Hospital
- University of Toronto
- University of Vienna
- University of Minnesota
- University of Sao Paulo
- Universidad Autonoma de Barcelona
- Pinnacle Health
- University of Poitiers
- University of Colorado
- Canadian Institutes of Health Research (CIHR)
- National Bank of Austria
- Institut Hospital del Mar d'Investigacions Mèdiques
- Maryland Cigarette Restitution Fund
- Government College University Faisalabad
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (37)
- Mallinckrodt
- Cairo University
- Coastal Anesthesiology Consultants
- Lovisenberg Diakonale Hospital
- McGill University
- McLaren Health Care
- McMaster University
- Min-Sheng General Hospital
- Singapore General Hospital
- Stanford University
- University Hospital of North Norway
- University of South Carolina
- University of Tromso
- Zuyderland Medisch Centrum
- Nazareth Hospital
- Tel Aviv University
- Medical University of South Carolina
- Jiao Tong University
- Emek Medical Center
- Federal University of Santa Catarina
- National University of Singapore
- Hebrew University
- Pontificia Universidade Católica do RS
- King Khalid University
- Technion University
- Nordland Hospital
- Oregon Weight Loss Surgery
- University of Texas at Houston
- University of Gothenburg
- Nazareh Hospital - Mercy Health System
- +7 more